Lasa Supergenerics share news and announcements
NSE: LASABSE: 540702Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 19 Oct 2026. Previous close ₹5.16.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹25 Cr3,595th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 0.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Sep 2026
- −24.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Sep 2026
- −24.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day.
- 37,588
Lasa Supergenerics share news and announcements
825 announcements, routine notices left out, newest first. Page 5 of 17.
Apr 2024
29 Apr · YEARLY CERTIFICATE FROM PRACTICING COMPANY SECRETARY UNDER REG 40(9) OF SEBI (LODR) REGULATIONS 2015
15 Apr · Compliance Under Reg 7(3) SEBI LODR, Regulations 2015 For The Period Ended March 31, 2024
Mar 2024
11 Mar · Board meeting
8 Mar · Board meeting
Feb 2024
13 Feb · Board meeting
Jan 2024
Dec 2023
14 Dec · Legal
Exchange has sought clarification from Lasa Supergenerics Limited for the quarter ended 30-Sep-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.14 Dec · Legal
Clarification - Financial Results
Nov 2023
10 Nov · Board meeting
Oct 2023
10 Oct · Disclosure of material issue
10 Oct · Material Event Update In Compliance With Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015,
Sep 2023
28 Sep · Meeting
2 Sep · Board meeting
Aug 2023
14 Aug · Board meeting
Jul 2023
27 Jul · Address Change
27 Jul · Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
Jun 2023
9 Jun · Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
9 Jun · Board meeting
7 Jun · Board meeting
Meeting on 9 Jun 2023: audited results and quarterly results
May 2023